Tesis sobre el tema "Macrophage inhibitory cytokine - 1"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 25 mejores tesis para su investigación sobre el tema "Macrophage inhibitory cytokine - 1".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore tesis sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Patrikainen, Lila. "Prostatic gene expression : probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes /". Oulu : Oulun yliopisto, 2004. http://herkules.oulu.fi/isbn9514272730/.
Texto completoPatrikainen, L. (Lila). "Prostatic gene expression: probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes". Doctoral thesis, University of Oulu, 2004. http://urn.fi/urn:isbn:9514272730.
Texto completoRasiah, Krishan Kumar St Vincent's UNSW. "The identification of novel biomarkers in the development and progression of early prostate cancer". Awarded by:University of New South Wales. St Vincent's, 2006. http://handle.unsw.edu.au/1959.4/24187.
Texto completoMontero, Rosa Maria. "Chemokines and macrophage migration inhibitory factor in diabetic nephropathy". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/29851.
Texto completoPowell, Nicole Damico. "Immunomodulation of experimental autoimmune encephalomyelitis targeting the autoreactive T cell and the cytokine macrophage migration inhibitory factor /". Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1141052089.
Texto completoRussell, Kirsty. "The role of macrophage migration inhibitory factor in airways disease". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/23917.
Texto completoNguyen, Tuyet Mai. "Elucidation of thiol-protein oxidoreductase activity of the cytokine macrophage migration inhibitory factor (MIF) by biochemical redox and site-specific mutagenesis analysis". [S.l. : s.n.], 2003. http://www.bsz-bw.de/cgi-bin/xvms.cgi?SWB10520514.
Texto completoLiu, Yu. "The role of suppressors of cytokine signalling 1 and 3 in macrophage activation". Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources, 2008. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=24848.
Texto completoBaeza, Garcia Alvaro. "Rôle de MIF (Macrophage Migration Inhibitory Factor) dans l'immunité innée et la réponse anti-schistosome chez Biomphalaria glabrata". Phd thesis, Université du Droit et de la Santé - Lille II, 2010. http://tel.archives-ouvertes.fr/tel-00665113.
Texto completoTamaki, Hiroyuki. "Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production". Kyoto University, 2007. http://hdl.handle.net/2433/135755.
Texto completoNicaise, Pascale. "Effets modulateurs de la flore intestinale sur les marqueurs membranaires et la production de cytokines (il-1, il-6, tnf alpha et il-12) de macrophages de souris (doctorat : microbiologie)". Paris 11, 1998. http://www.theses.fr/1998PA114844.
Texto completoBaía, Diogo Nogueira de Graça 1984. "Role of the LILRB1 HLA class I-specific inhibitory receptor in the regulation of macrophage function". Doctoral thesis, Universitat Pompeu Fabra, 2014. http://hdl.handle.net/10803/380898.
Texto completoEn aquest projecte hem analitzat la participació del receptor inhibidor específic per HLA de classe I: LILRB1, en la regulació de la funció dels macròfags humans (MΦ). Els macròfags M1 i M2 diferenciats in vitro expressen nivells diferents de LILRB1. Aportem evidències experimentals que recolzen el paper de la interacció LILRB1/HLA-I com element regulador del llindar d’activació en la homeòstasi del macròfag, influint en la secreció de citocines en condicions basals així com en resposta a cèl.lules tumorals i a la senyalització de receptors activadors dependents de motius ITAM. D’altra banda, les nostres observacions indiquen que el reconeixement de cèl.lules diana per part de LILRB1 es dóna independentment del nivell d’expressió de les molècules del HLA en la seva superfície, però correlaciona amb la dimerització d’aquestes molècules. Aquest canvi conformacional, detectat en MΦ tractats amb interferons de tipus I, s’associa a un increment de la interacció entre LILRB1 i HLA-I, suggerint un possible mecanisme regulador de l’activació del MΦ.
Praloran, Vincent. "Etude du csf-1 dans la pathologie hematolymphoide : analyse de la production lymphocytaire t et sa regulation". Nantes, 1991. http://www.theses.fr/1991NANT04VS.
Texto completoKarathanos, Athanasios [Verfasser] y Tobias [Akademischer Betreuer] Geisler. "Macrophage migration inhibitory factor and gremlin-1 in patients with coronary artery disease and diabetes : patterns of expression and interaction / Athanasios Karathanos ; Betreuer: Tobias Geisler". Tübingen : Universitätsbibliothek Tübingen, 2018. http://d-nb.info/1196701288/34.
Texto completoPons, Isabelle. "Synthèse des cytokines proinflammatoires et expression des molécules d'adhérence par le monocyte/macrophage humain irradié". Paris 5, 1997. http://www.theses.fr/1997PA05S027.
Texto completoAlexander, Lindsey Ann. "The Role of Inflammation in Diet-Induced Insulin Resistance". University of Toledo / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1260808416.
Texto completoDerrien, Danièle. "Modulateur de la réponse immune : ciblage par des polymères glycosyles reconnus par les lectines membranaires des macrophages murins". Orléans, 1988. http://www.theses.fr/1988ORLE2037.
Texto completoChumble, Anuja. "Epigenetic Alterations of Toll-Like Receptors by TET2 in Spontaneous Preterm Labor". VCU Scholars Compass, 2014. http://scholarscompass.vcu.edu/etd/3469.
Texto completoBritto, Karen Elma. "The Role of Discoidin Domain Receptor 1 (Ddr1) on Macrophages in Adhesion and Cytokine Production". Thesis, 2010. http://hdl.handle.net/1807/25438.
Texto completoBélanger, Benoît. "La neutralisation du facteur d'inhibition de migration des macrophages (MIF) augmente la sécrétion du TNF-a et module la sécrétion d'IFN-y durant l'infection par plasmodium chabaudi adami". Mémoire, 2008. http://www.archipel.uqam.ca/1475/1/M10597.pdf.
Texto completoLi, Chen-yu y 李晨宇. "Inhibitory effect of microwave radiation on LPS-induced NFκB cytokine expression in the THP-1 monocytes". Thesis, 2010. http://ndltd.ncl.edu.tw/handle/zaw97z.
Texto completo元培科技大學
醫學檢驗生物技術研究所
98
Microwave radiations, can be encountered regularly in daily lives. When World Health Organization (WHO) announced that microwave radiations as a kind of environmental energy which interferes with the physiological functions of human body, great concerns have been raised over the damage frequency can do to human physiology. The immunological performance and the activeness of cellular inflammatory factor NFκB have been closely related in monocyte. Due to the effect of phorbol 12-myristate 13-acetate (PMA) to THP-1 monocytes, THP-1 monocytes will divide into macrophages and will then react with lipopolysaccharides (LPS), and the amount of NFκB cytokine increases in THP-1 monocytes. Expression of cytokine will be affected when cells are exposed to frequency at 2450 MHz and are worked at 900W. Thus, from our experiments, an observation can be made when THP-1 monocytes are stimulated with PMA and LPS to differentiate into macrophage, the amount of NFκB cytokine in cells increases exponentially, and the level of expression is also restricted by the exposure of frequency. In conclusion, microwave radiations can inhibit the activity functions of THP-1 monocytes to be stimulated with PMA and LPS.
Kao, Yung-Ling y 高咏菱. "The regulation of polyunsaturated fatty acids (PUFAs) on macrophage migration inhibitory factor (MIF) in THP-1 macrophages". Thesis, 2012. http://ndltd.ncl.edu.tw/handle/65637995210095324682.
Texto completo國立陽明大學
生化暨分子生物研究所
100
Macrophage migration inhibitory factor (MIF) is an important pro-inflammatory cytokine and has presumed a vital role as a upstream regulator of host antimicrobial responses. Macrophages act as sentinel cells in the innate immune system. They play roles in destroying pathogens and releasing substances that act on other immune cells. MIF lacks an amino-terminal leader sequence, indicating that it is secreted from cells by a non-classical secretion pathway. Literatures report that MIF is implicated in the pathogenesis of sepsis and inflammatory diseases, suggesting that MIF might offer a therapeutic target for human diseases. Animal experiments and clinical studies demonstrate that n-3 polyunsaturated fatty acids (n-3 PUFAs) might also have the therapeutic effect on anti-inflammation. In this study, THP-1 macrophages were pretreated with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) for 24 hours before stimulation with LPS. The results showed that DHA and EPA inhibited LPS-induced MIF secretion, but these two n-3 PUFAs had no effect on the mRNA and protein levels of MIF. Immunoprecipitation analysis showed that LPS induced the interaction between MIF and ABCA1 which participates in MIF secretion pathway, and pretreatment of DHA and EPA suppressed the interaction. Furthermore, DHA and EPA repressed the colocalization of MIF and ABCA1 induced by LPS. SQ 22536, an inhibitor of protein kinase A (PKA), reversed the LPS-induced MIF secretion. Moreover, the interaction of MIF and ABCA1 was reduced in THP-1 macrophages pretreated with the PKA inhibitor in immunoprecipitation experiment. Thus, we suggest that LPS stimulates MIF secretion via activation of PKA signaling pathway. In conclusion, Our data reveal that DHA and EPA may inhibit LPS-induced MIF secretion by modulating the molecules involved in MIF secretion pathway and supply a novel insight to the mechanisms of n-3 PUFAs on anti-inflammation.
Nguyen, Tuyet Mai [Verfasser]. "Elucidation of thiol protein oxidoreductase activity of the cytokine macrophage migration inhibitory factor (MIF) by biochemical redox and site specific mutagenesis analysis / vorgelegt von Nguyen Tuyet Mai". 2003. http://d-nb.info/967671175/34.
Texto completoGoupil, Mathieu. "Analyse de la réponse macrophagique au Candida albicans chez la souris transgénique exprimant le génome du VIH-1". Thèse, 2009. http://hdl.handle.net/1866/4045.
Texto completoOro-pharyngeal candidiasis (OPC) is the most common opportunistic infection in HIV-1 infected patients. An OPC model using transgenic mice (CD4C/HIVMutA) expressing selected genes of the HIV-1 genome is now available. Using this model, it is now possible to study potential quantitative and functional disturbances in macrophages expressing the nef, rev and env genes of HIV-1 in the context of OPC. This study shows that transgene expression does not affect quantitative percentage values of macrophages in the oral mucosa and the small intestine, although burdens of C. albicans loads are increased in Tg mice. Transgene expression does induce diminished H2O2 production in macrophages, while increasing production of the proinflammatory cytokine IL-6 and the chemokine MCP-1.
Σταθάς, Θεόδωρος. "Μελέτη του ρυθμιστικού ρόλου του παράγοντα αναστολής της μετανάστευσης των μακροφάγων (MIF) στην επίδραση των κορτικοειδών στην παραγωγή μεταλλοπρωτεασών και των ενδογενών αναστολέων τους, κυτταροκινών και κολλαγόνου στο ρινικό πολύποδα". Thesis, 2012. http://hdl.handle.net/10889/6152.
Texto completoIn the present study we investigated the expression of macrophage migration inhibitory factor (MIF) in nasal polyp tissues and also in normal nasal mucosa. The ability of MIF to neutralize the inhibitory effect of glucocorticoids on various growth factors induced expression of IL-6, TIMP-1, collagen type-I and matrix metalloproteinases MMP-1 and MMP-3, involved in the pathogenesis of nasal polyps, was studied. MIF was detected in all polyp tissue extracts and tissue culture conditioned media and its expression was increased in nasal polyps compared with normal nasal mucosa. TGF-b1 caused a dose-and time-dependent increase in levels of IL-6 of TIMP-1 and collagen type-I, while the TNF-a induced a dose-and time-dependent stimulation in the production of IL-6 of TIMP-1 and metalloproteinases MMP-1 and MMP-3. Dexamethasone caused a statistically significant and dose-dependent reduction induced by TGF-b1 and TNF-a, production of IL-6 of TIMP-1 of collagen type-I and the metalloproteinases MMP-1 and MMP-3. Investigating the mechanism by which dexamethasone exercises the suppressive action on both induced by TGF-b1 and by TNF-a, production of IL-6, showed that this occurs mainly through the induction and protection of MKP-1 and hence the suppression of the MAPK pathway and activation of AP-1, and less through the suppression of the activation of NF-kB. The ISO-1, an inhibitor of the action of MIF, significantly enhanced the suppressive effect of dexamethasone on the levels of IL-6 and TIMP-1 in tissue culture medium from nasal polyps. In contrary, ISO-1 induced inversion of the suppresive action of dexamethasone, which was statistically significant for MMP-1 but not for MMP-3. Enhancing of the suppresive action of dexamethasone in the presence of ISO-1, which ranged from 15.0% to 20.5% would probably be due to inhibition of endogenous MIF by ISO-1. In conclusion, the presence of MIF in nasal polyp tissue, appears to attenuate the suppressor effect of dexamethasone on the production of IL-6 and TIMP-1by this tissue, while simultaneously using the inhibitor of MIF, ISO-1 leads to an enhancement of dexamethasone activity. Therefore, it is reasonable to propose that the creation of a pharmaceutical regimen containing cortisol and an inhibitor of MIF, might be more effective in the treatment of nasal polyposis. Of course, requires further experiments with a combination of glucocorticoids and MIF inhibitors to study their effect on production of other factors involved in the pathogenesis of nasal polyposis in order to draw safer conclusions.